Literature DB >> 21052879

Graft failure in cord blood transplantation successfully treated with short-term reduced-intensity conditioning regimen and second allogeneic transplantation.

Masahiko Sumi1, Ikuo Shimizu, Keijiro Sato, Toshimitsu Ueki, Daigo Akahane, Mayumi Ueno, Naoaki Ichikawa, Shinji Nakao, Hikaru Kobayashi.   

Abstract

Graft failure (GF) remains a major problem in cord blood transplantation (CBT). In 36 adult patients undergoing CBT at our hospital between July 2003 and December 2009, six patients developed GF (primary, n = 5; secondary, n = 1). All six patients underwent second stem cell transplantation (SCT). Three patients had acute myeloid leukemia, one had acute lymphoblastic leukemia, one had chronic myeloid leukemia, and one had aplastic anemia. Five patients were complicated with sepsis before the second SCT. The median elapsed time from first CBT to the diagnosis of primary GF was 27 days. Secondary GF was diagnosed on day 567. The median elapsed time from primary GF to second SCT was 9 days. In the patient with secondary GF, the elapsed time was 35 days. Cord blood grafts were used in 5 patients and a matched sibling donor in one patient. All 6 patients underwent second transplantation following a modified '1-day'-based preparative regimen consisting of fludarabine (30 mg/m(2), 1 day, n = 2; 2 days, n = 1; 3 days, n = 3), cyclophosphamide (2 g/m(2)), and total body irradiation (2 Gy). All patients achieved neutrophil engraftment, and the median elapsed time from second SCT to engraftment was 35 days. Four patients remain alive between 5 and 38 months after second SCT. '1-day'-based short-term conditioning may be a promising salvage regimen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21052879     DOI: 10.1007/s12185-010-0714-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

1.  Second early allogeneic stem cell transplantations for graft failure in acute leukaemia, chronic myeloid leukaemia and aplastic anaemia. French Society of Bone Marrow Transplantation.

Authors:  P Guardiola; M Kuentz; F Garban; D Blaise; J Reiffers; M Attal; A Buzyn; B Lioure; P Bordigoni; N Fegueux; M L Tanguy; J P Vernant; E Gluckman; G Socié
Journal:  Br J Haematol       Date:  2000-10       Impact factor: 6.998

2.  Successful engraftment by second cord blood transplantation with reduced-intensity conditioning after graft rejection due to hemophagocytic syndrome following initial CBT.

Authors:  H Tanaka; C Ohwada; E Sakaida; Y Takeda; D Abe; K Oda; S Ozawa; N Shimizu; S Masuda; R Cho; M Nishimura; Y Saito; C Nakaseko
Journal:  Bone Marrow Transplant       Date:  2007-09-03       Impact factor: 5.483

3.  Human herpesvirus-6 encephalitis in hematopoietic SCT recipients in Japan: a retrospective multicenter study.

Authors:  T Muta; T Fukuda; M Harada
Journal:  Bone Marrow Transplant       Date:  2008-11-03       Impact factor: 5.483

4.  Second transplantation from HLA 2-loci-mismatched mother for graft failure due to hemophagocytic syndrome after cord blood transplantation.

Authors:  Takayuki Tanaka; Hiroshi Matsubara; Souichi Adachi; Hsi Chang; Hisanori Fujino; Yuri Higashi; Takahiro Yasumi; Michihiro Kobayashi; Ken-ichiro Watanabe; Munehisa Takahashi; Yoshiro Kobayashi; Etsuko Maruya; Hiroh Saji; Tatsutoshi Nakahata
Journal:  Int J Hematol       Date:  2004-12       Impact factor: 2.490

Review 5.  Human herpesvirus 6 in hematological malignancies.

Authors:  Masao Ogata
Journal:  J Clin Exp Hematop       Date:  2009-11

Review 6.  Graft failure after allogeneic hematopoietic cell transplantation.

Authors:  Jonas Mattsson; Olle Ringdén; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2008-01       Impact factor: 5.742

7.  Cord blood transplantation using minimum conditioning regimens for patients with hematologic malignancies complicated by severe infections.

Authors:  Takeshi Yamashita; Chiharu Sugimori; Ken Ishiyama; Hirohito Yamazaki; Hirokazu Okumura; Yukio Kondo; Akiyoshi Takami; Shinji Nakao
Journal:  Int J Hematol       Date:  2008-12-25       Impact factor: 2.490

8.  Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.

Authors:  Gabriela Rondón; Rima M Saliba; Issa Khouri; Sergio Giralt; Kawah Chan; Elias Jabbour; John McMannis; Richard Champlin; Elizabeth Shpall
Journal:  Biol Blood Marrow Transplant       Date:  2008-08       Impact factor: 5.742

9.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.

Authors:  Boglarka Gyurkocza; Thai M Cao; Rainer F Storb; Thoralf Lange; Wendy Leisenring; Georg N Franke; Mohamed Sorror; Richard Hoppe; David G Maloney; Robert S Negrin; Judith A Shizuru; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2009-08-03       Impact factor: 5.742

10.  Correlations of HHV-6 viral load and plasma IL-6 concentration with HHV-6 encephalitis in allogeneic stem cell transplant recipients.

Authors:  M Ogata; T Satou; R Kawano; S Takakura; K Goto; J Ikewaki; K Kohno; T Ikebe; T Ando; Y Miyazaki; E Ohtsuka; Y Saburi; T Saikawa; J Kadota
Journal:  Bone Marrow Transplant       Date:  2009-05-25       Impact factor: 5.483

View more
  8 in total

1.  Successful early unmanipulated haploidentical transplantation with reduced-intensity conditioning for primary graft failure after cord blood transplantation in hematologic malignancy patients.

Authors:  B L Tang; X Y Zhu; C C Zheng; H L Liu; L Q Geng; X B Wang; K Y Ding; W Yao; J Tong; K D Song; L Zhang; P Qiang; Z M Sun
Journal:  Bone Marrow Transplant       Date:  2014-11-03       Impact factor: 5.483

2.  Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.

Authors:  K Ishiyama; J Takeda; T Kondo; N Sugimoto; H Kawabata; T Kitano; A Takaori-Kondo
Journal:  Bone Marrow Transplant       Date:  2016-02-15       Impact factor: 5.483

3.  Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.

Authors:  Takumi Hoshino; Satoru Takada; Nahoko Hatsumi; Toru Sakura
Journal:  Int J Hematol       Date:  2019-02-08       Impact factor: 2.490

4.  Second allogeneic hematopoietic cell transplantation for graft failure: poor outcomes for neutropenic graft failure.

Authors:  Troy C Lund; Jessica Liegel; Nelli Bejanyan; Paul J Orchard; Qing Cao; Jakub Tolar; Claudio Brunstein; John E Wagner; Michael R Verneris; Daniel Weisdorf
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

5.  Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation.

Authors:  J Kanda; M E Horwitz; G D Long; C Gasparetto; K M Sullivan; J P Chute; A Morris; T Hennig; Z Li; N J Chao; D A Rizzieri
Journal:  Bone Marrow Transplant       Date:  2011-08-01       Impact factor: 5.483

6.  Intrathecal administration of high-titer cytomegalovirus immunoglobulin for cytomegalovirus meningitis.

Authors:  Shin-Ichiro Fujiwara; Kazuo Muroi; Raine Tatara; Ken Ohmine; Tomohiro Matsuyama; Masaki Mori; Tadashi Nagai; Keiya Ozawa
Journal:  Case Rep Hematol       Date:  2014-05-08

7.  Salvage Cord Blood Transplantation Using a Short-term Reduced-intensity Conditioning Regimen for Graft Failure.

Authors:  Sakurako Suma; Yasuhisa Yokoyama; Haruka Momose; Kenichi Makishima; Yusuke Kiyoki; Tatsuhiro Sakamoto; Manabu Kusakabe; Takayasu Kato; Naoki Kurita; Hidekazu Nishikii; Mamiko Sakata-Yanagimoto; Naoshi Obara; Yuichi Hasegawa; Shigeru Chiba
Journal:  Intern Med       Date:  2021-11-20       Impact factor: 1.282

8.  Stem cell transplant: An experience from eastern India.

Authors:  A Mukhopadhyay; P Gupta; J Basak; A Chakraborty; D Bhattacharyya; S Mukhopadhyay; U K Roy
Journal:  Indian J Med Paediatr Oncol       Date:  2012-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.